To investigate the characteristics and clinical course of cerebral vein thrombosis (CVT) in patients with myeloproliferative neoplasms (MPN) we compared 48 patients with MPN and CVT (group MPN-CVT) to 87 with MPN and other venous thrombosis (group MPN-VT) and 178 with MPN and no thrombosis (group MPN-NoT) matched by sex, age at diagnosis of MPN (+/-5 years) and type of MPN. The study population was identified among 5,500 patients with MPN, from January 1982 to June 2013. Thrombophilia abnormalities were significantly more prevalent in the

Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study / Martinelli, I; De Stefano, V; Carobbio, A; Randi, Ml; Santarossa, C; Rambaldi, A; Finazzi, Mc; Cervantes, F; Arellano-Rodrigo, E; Rupoli, S; Canafoglia, L; Tieghi, A; Facchini, L; Betti, S; Vannucchi, Am; Pieri, L; Cacciola, R; Cacciola, E; Cortelezzi, A; Iurlo, A; Pogliani, Em; Elli, Em; Spadea, A; Barbui, T. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 1096-8652. - 89:11(2014), pp. E200-E205. [10.1002/ajh.23809]

Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study

Carobbio A;
2014

Abstract

To investigate the characteristics and clinical course of cerebral vein thrombosis (CVT) in patients with myeloproliferative neoplasms (MPN) we compared 48 patients with MPN and CVT (group MPN-CVT) to 87 with MPN and other venous thrombosis (group MPN-VT) and 178 with MPN and no thrombosis (group MPN-NoT) matched by sex, age at diagnosis of MPN (+/-5 years) and type of MPN. The study population was identified among 5,500 patients with MPN, from January 1982 to June 2013. Thrombophilia abnormalities were significantly more prevalent in the
2014
89
11
E200
E205
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study / Martinelli, I; De Stefano, V; Carobbio, A; Randi, Ml; Santarossa, C; Rambaldi, A; Finazzi, Mc; Cervantes, F; Arellano-Rodrigo, E; Rupoli, S; Canafoglia, L; Tieghi, A; Facchini, L; Betti, S; Vannucchi, Am; Pieri, L; Cacciola, R; Cacciola, E; Cortelezzi, A; Iurlo, A; Pogliani, Em; Elli, Em; Spadea, A; Barbui, T. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 1096-8652. - 89:11(2014), pp. E200-E205. [10.1002/ajh.23809]
Martinelli, I; De Stefano, V; Carobbio, A; Randi, Ml; Santarossa, C; Rambaldi, A; Finazzi, Mc; Cervantes, F; Arellano-Rodrigo, E; Rupoli, S; Canafoglia, L; Tieghi, A; Facchini, L; Betti, S; Vannucchi, Am; Pieri, L; Cacciola, R; Cacciola, E; Cortelezzi, A; Iurlo, A; Pogliani, Em; Elli, Em; Spadea, A; Barbui, T
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1331672
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 36
social impact